Clinical Trial Update: Imaging of Active Granulomas With [18F]FDG and Selected Inflammatory PET Tracers in Pulmonary Sarcoidosis [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update discusses Phase 2/Phase 3 imaging studies evaluating active granulomas in pulmonary sarcoidosis using [18F]FDG and selected inflammat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Sarcoidosis

Drugs mentioned

• 18F-FDG (fluorodeoxyglucose F-18)

Snippet

Sponsor: Turku University Hospital | Conditions: Pulmonary Sarcoidosis | Phase 2, Phase 3 | Status: UNKNOWN